MTOR and colorectal cancer: Wu et al. reported increased expression levels of Beclin1, LC3, and mTOR in colorectal cancer cells, which the increased LC3 expression levels exhibited a positive correlation with increased Beclin1 and cell differentiation and negative correlation with mTOR expression levels.